Vilnius-Utrecht Center opens as a hub for emerging research leaders in Advanced Disease Modeling

Date:
Vilnius-Utrecht-Center-hub

A new international research hub has officially opened its doors: the Vilnius–Utrecht Center for Advanced Disease Modeling. This strategic initiative unites Vilnius University in Lithuania (in close partnership with Vilnius University Hospital Santaros Klinikos), UMC Utrecht, and Utrecht University . Its mission is to build an internationally competitive translational research environment that accelerates discovery, diagnostic innovation, and personalized medicine.

Modern medicine faces increasingly complex challenges, from cancer and neurodegenerative diseases to immune disorders, circulatory health and rare diseases. Developing innovative solutions requires collaboration across borders, disciplines, and technologies. The Vilnius-Utrecht Center for Advanced Disease Modeling (CADM) brings together the complementary strengths of two leading biomedical ecosystems: the newly established state-of-the-art complex of the Vilnius University’s Medical Science Center, and the internationally recognized Life Sciences expertise of UMC Utrecht and Utrecht University.

“This center is designed as a catalyst for new ideas,” says Professor Roos Masereeuw, Vice-Dean Research at the Faculty of Science of Utrecht University. “By combining cutting-edge technologies with an open, collaborative culture, we aim to empower researchers to push boundaries and turn scientific insights into tangible benefits for patients and society.”

A vision for impact

The center aims to become a jointly built European reference point for clinically relevant disease modeling, grounded in scientific excellence and innovation. The center will integrate advanced in vitroex vivo, and in silico technologies. This includes organoid biology, iPSC, spatial and single-cell omics, 3D bioprinting, and AI-driven analytics. Together, these approaches form a seamless translational pipeline linking experimental models to clinical implementation.

“We are creating an environment where ambitious scientists can thrive,” adds Professor Paul Coffer, Vice-Dean Life Sciences at Utrecht University. “If you have a bold vision for advanced disease modeling, this is your chance to make it happen.”

Opportunities

The center is now inviting Principal Investigators to establish independent research groups within this international hub. Successful candidates will receive a start-up package to build their team, access to state-of-the-art facilities in both Vilnius and Utrecht, support for relocation to Vilnius and integration, opportunities for joint projects, research visits to Utrecht, and co-supervision.

Strategic positioning

By bridging the Baltic region and the Netherlands, the center occupies a unique position at the intersection of fundamental biosciences, clinical research, and computational innovation. Its integrated ecosystem-spanning biobanking, clinical datasets, imaging platforms, and digital pathology- offers researchers the tools and networks to deliver impactful translational research. The recruitment of four international Principal Investigators will anchor the center’s scientific capacity and establish it as a training hub for future leaders. Together, the diverse components enable the center to function as a translational bridge between research and innovation, and clinical implementation, supported by a comprehensive, cross-border scientific ecosystem.

More news

News overview

Registration for Utrecht Science Week 2026 is now open: the knowledge festival at Utrecht Science Park

From Friday 25 September to Sunday 4 October, the sixth edition of Utrecht Science Week will take place. Utrecht Science Park will open its doors to everyone interested in (applied) science and innovation in the fields of life sciences, health, and sustainability.

The first programme elements have now been announced and registration is open. Many more events and activities will be added to the programme in the coming weeks.

New artificial heart implanted for the first time in Europe

Earlier this month at UMC Utrecht, a patient with advanced heart failure became the first person in Europe to receive a BrioVAD ventricular assist device. The new system is being evaluated in a European study and may offer advantages over the existing ventricular assist device. For UMC Utrecht, the implantation marks a new milestone in a long history of innovation in the field of mechanical circulatory support.

Successful first edition of Utrecht Life Sciences TechConnect

On 4 June 2026, researchers, technology experts, facility staff and innovation partners from across the Utrecht Life Sciences community gathered at Utrecht Science Park for the first edition of Utrecht Life Sciences TechConnect. The new annual event was created to strengthen connections between researchers and technology facilities, showcase advanced research technologies, and stimulate collaboration across disciplines.

Opening Utrecht Science Week with keynote by Juliette Legler on the hidden influence of environmental chemicals

On Friday, September 25, the annual science festival ‘Utrecht Science Week’ kicks off once again at Utrecht Science Park. We are pleased to announce that this year, Prof. Dr. Ir. Juliette Legler will deliver the Utrecht Science Lecture. Juliette Legler is Professor of Toxicology at the Faculty of Veterinary Medicine at Utrecht University and leads the ‘One Health Toxicology’ group at the Institute for Risk Assessment Sciences (IRAS).